Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
{{output}}
Diffuse large B-cell lymphoma (DLBCL) patients that fail to achieve a complete metabolic response with frontline immunochemotherapy have a poor prognosis. Genomic profiling has led to a broader understanding of the molecular drivers in DLBCL, but it is unknown... ...
